Work is underway to analyze possible changes in the motility and invasive potential of MGRN1-depleted human melanoma cells, and to further probe the clinical application of the determination of MGRN1 expression levels in melanoma by the analysis of larger cohorts of patients. Here, MGRN1 is linked to melanoma.